ANDREA WILD-GINGELESKI: Open Payments
NPI 1447923719 · BEDFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 16 payments from 6 companies in 2025. Trend: 2023 $222 · 2024 $410 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $244 |
| Alkermes, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VIVITROL, Ozempic, FARXIGA, Wegovy, UZEDY, MOUNJARO, REXULTI, Rybelsus.
Industry payments across VA — which companies pay providers there.
